The National Rosacea Society has awarded funding for two new studies, in addition to continuing support for one ongoing study, as part of its research grants program to increase knowledge and understanding of the potential causes and other key aspects of rosacea that may lead to improvements in its treatment, prevention or potential cure.
A recent NRS-funded study found that a computer-assisted analysis tool may improve the visual assessment practices that dermatologists use to evaluate rosacea.1 This initial research increases the possibility that doctors and rosacea sufferers may one day have access to technology that is less subjective and variable than today’s most common diagnostic methods.
Every person is host to a natural mix of bacteria, fungi and viruses — they are normal inhabitants of the skin, known as the skin microbiome. But the makeup of that community may be very different in those with rosacea, according to the results of a recent NRS-funded study comparing the bacteria found on the faces of rosacea patients and people without the condition.
More than two decades ago, rosacea was a poorly understood condition that was often considered a rare disease. Today it is estimated that more than 16 million Americans suffer from its conspicuous and embarrassing signs and symptoms, and the good news is that the advancement of scientific knowledge and treatment of rosacea has kept pace with its far wider recognition.
The NRS Research Grants Program has awarded funding for a new study in addition to continued support for three ongoing studies in its mission to help increase knowledge and understanding of the causes and other key aspects of rosacea that may lead to improvement in its management, prevention or potential cure.
A new advance in the understanding of mast cells, located at the interface between the nervous and vascular systems, in the development of rosacea is at the center of a recent study funded by a National Rosacea Society research grant and conducted by a team led by Dr. Anna Di Nardo, professor of medicine at the University of California-San Diego.
Over the course of nearly two decades since the National Rosacea Society (NRS) issued its first research grants, this program has fostered dramatic strides in the understanding of rosacea, and has now awarded more than $1.5 million to date.1 Funded exclusively by donations from individuals, the NRS research grants program was established in 1999 to provide support for medical research into the potential causes and other key aspects of this poorly understood disorder that may lead to improvements in its treatment, care and potential cure.
The National Rosacea Society (NRS) has awarded funding for three new studies, in addition to continuing support for three ongoing studies.
The National Rosacea Society has awarded funding for three new studies, in addition to continuing support for two ongoing studies, as part of its research grants program. The purpose of the grant program is to increase knowledge and understanding of the causes and other key aspects of rosacea that may lead to improvements in its management, prevention or potential cure.
Kallikrein-related peptidases (KLKs), a family of proteases recently identified as having a possible role in the development of rosacea, may help provide a pathway to controlling rosacea’s signs and symptoms, according to an article by Drs. Jan Fischer and Ulf Meyer-Hoffert of the University Hospital Schleswig-Holstein in Germany in the journal Thrombosis and Haemostasis.